Home
/
HAEMONETICS CORP
/
Financials
/
Quarterly
HAEMONETICS CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HAEMONETICS CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 27, 2025
$338.97M
Feb 5, 2026
Q2
2026
Sep 27, 2025
$327.32M
Nov 6, 2025
Q1
2026
Jun 28, 2025
$321.39M
Aug 7, 2025
Q3
2026
Dec 28, 2024
$348.54M
Feb 5, 2026
Q2
2026
Sep 28, 2024
$345.51M
Nov 6, 2025
Q1
2026
Jun 29, 2024
$336.17M
Aug 7, 2025
Q3
2025
Dec 30, 2023
$336.25M
Feb 6, 2025
Q2
2025
Sep 30, 2023
$318.18M
Nov 7, 2024
Q1
2025
Jul 1, 2023
$311.33M
Aug 8, 2024
Q3
2024
Dec 31, 2022
$305.30M
Feb 8, 2024
Q2
2024
Oct 1, 2022
$297.49M
Nov 2, 2023
Q1
2024
Jul 2, 2022
$261.46M
Aug 8, 2023
Q3
2023
Jan 1, 2022
$259.77M
Feb 7, 2023
Q2
2023
Oct 2, 2021
$239.90M
Nov 8, 2022
Q1
2023
Jul 3, 2021
$228.53M
Aug 10, 2022
Q3
2022
Dec 26, 2020
$240.37M
Feb 8, 2022
Q2
2022
Sep 26, 2020
$209.49M
Nov 9, 2021
Q1
2022
Jun 27, 2020
$195.58M
Aug 11, 2021
Q3
2021
Dec 28, 2019
$258.97M
Feb 2, 2021
Q2
2021
Sep 28, 2019
$252.57M
Nov 4, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 27, 2025
$44.74M
Feb 5, 2026
Q2
2026
Sep 27, 2025
$38.68M
Nov 6, 2025
Q3
2026
Sep 27, 2025
$38.68M
Feb 5, 2026
Q2
2026
Jun 28, 2025
$34.03M
Nov 6, 2025
Q3
2026
Jun 28, 2025
$34.03M
Feb 5, 2026
Q1
2026
Jun 28, 2025
$34.03M
Aug 7, 2025
Q3
2026
Dec 28, 2024
$37.49M
Feb 5, 2026
Q2
2026
Sep 28, 2024
$33.83M
Nov 6, 2025
Q3
2026
Sep 28, 2024
$33.83M
Feb 5, 2026
Q1
2026
Jun 29, 2024
$38.37M
Aug 7, 2025
Q2
2026
Jun 29, 2024
$38.37M
Nov 6, 2025
Q3
2026
Jun 29, 2024
$38.37M
Feb 5, 2026
Q3
2025
Dec 30, 2023
$31.24M
Feb 6, 2025
Q3
2025
Sep 30, 2023
$24.91M
Feb 6, 2025
Q2
2025
Sep 30, 2023
$24.91M
Nov 7, 2024
Q3
2025
Jul 1, 2023
$41.04M
Feb 6, 2025
Q1
2025
Jul 1, 2023
$41.04M
Aug 8, 2024
Q2
2025
Jul 1, 2023
$41.04M
Nov 7, 2024
Q3
2024
Dec 31, 2022
$32.94M
Feb 8, 2024
Q2
2024
Oct 1, 2022
$33.20M
Nov 2, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Dec 27, 2025
$67.40M
Feb 5, 2026
Q2
2026
Sep 27, 2025
$58.49M
Nov 6, 2025
Q1
2026
Jun 28, 2025
$53.87M
Aug 7, 2025
Q3
2026
Dec 28, 2024
$59.03M
Feb 5, 2026
Q2
2026
Sep 28, 2024
$51.70M
Nov 6, 2025
Q1
2026
Jun 29, 2024
$39.76M
Aug 7, 2025
Q3
2025
Dec 30, 2023
$45.98M
Feb 6, 2025
Q2
2025
Sep 30, 2023
$35.30M
Nov 7, 2024
Q1
2025
Jul 1, 2023
$53.66M
Aug 8, 2024
Q3
2024
Dec 31, 2022
$43.28M
Feb 8, 2024
Q2
2024
Oct 1, 2022
$46.73M
Nov 2, 2023
Q1
2024
Jul 2, 2022
$30.77M
Aug 8, 2023
Q3
2023
Jan 1, 2022
$35.65M
Feb 7, 2023
Q2
2023
Oct 2, 2021
$24.51M
Nov 8, 2022
Q1
2023
Jul 3, 2021
$1.39M
Aug 10, 2022
Q3
2022
Dec 26, 2020
$40.43M
Feb 8, 2022
Q2
2022
Sep 26, 2020
$58.78M
Nov 9, 2021
Q1
2022
Jun 27, 2020
$11.72M
Aug 11, 2021
Q3
2021
Dec 28, 2019
$40.91M
Feb 2, 2021
Q2
2021
Sep 28, 2019
$49.74M
Nov 4, 2020